OncoResponse

0 followers

‌

OncoResponse leverages the power of the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of antibody-derived therapeutics for the treatment of cancer.

Industries

Headquarters

Employees

Links

Org chart

Clifford J. Stocks

Chief Executive Officer

Clifford J. Stocks

Collapse

Chris Russell

Chief Financial Officer

Kamal D. Puri

Chief Scientific Officer

Myriam Bouchlaka

Director Immuno-Oncology

Teams

Directors

8 members

Advisory Team

7 members

Leadership Team

3 members

Similar companies

Edelman

25 followers

NielsenIQ

8 followers

Product Marketing Alliance

1 follower

OpenAI

223 followers

dscout

4 followers

Redpoint Ventures

13 followers

inDrive

8 followers

ZEO ScientifiX

6 followers

Blank Street

6 followers

Primary Venture Partners

4 followers

School District of Philadelphia

4 followers

Discover companies